Evelo Biosciences Inc (EVLO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Balkrishan Gill
Employees:
120
620 MEMORIAL DRIVE, SUITE 200 WEST, CAMBRIDGE, MA 02139
617 870 8281

Evelo Biosciences, Inc. discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company also develops EDP1815, a whole-microbe candidate for the. treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19.

Data derived from most recent annual or quarterly report
Market Cap 16.418 Million Shares Outstanding110.93 Million Avg 30-day Volume 1.013 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.98
Price to Revenue0.0 Debt to Equity-1.5983 EBITDA-101.784 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value36.343 Million
Current Ratio0.526 EPS Growth0.578 Quick Ratio0.48
1 Yr BETA 1.5769 52-week High/Low 3.29 / 0.02 Profit Margin0.0
Operating Cash Flow Growth6.8406 Altman Z-Score-27.2613 Free Cash Flow to Firm -71.971 Million
Earnings Report2023-08-14
View SEC Filings from EVLO instead.

View recent insider trading info

Evelo Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding EVLO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EVLO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4/A: filed on 2023-05-10 by GILL SIMBA
  • 4: filed on 2023-05-09 by THORELL MARELLA
  • 4: filed on 2023-05-09 by GILL SIMBA
  • 4: filed on 2023-04-18 by ROSIELLO ROBERT L.
  • 3: filed on 2023-04-18 by ROSIELLO ROBERT L.
  • 4: filed on 2023-02-09 by GILL SIMBA
  • 4: filed on 2023-02-09 by BODMER MARK
  • 4: filed on 2023-02-09 by MCHALE DUNCAN
  • 4: filed on 2023-02-09 by THORELL MARELLA
  • 4: filed on 2023-02-02 by PLINIO MARK D.

    • Events (8k)

  • 8-K: filed on 2023-05-31:
    Item 8.01: Other Events
  • 8-K: filed on 2023-05-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-05-22:
    Item 8.01: Other Events
  • 8-K: filed on 2023-05-01:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-04-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-17:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-03-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-02-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-02-02:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    176.8 Thousand total shares from 4 transactions

    Exercise Derivative Conversion (M)

    415.9 Thousand total shares from 4 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    GILL SIMBA PRESIDENT & CEO

    • Officer
    • Director
    		 58,512 2023-05-08 4

    BODMER MARK CSO, PRESIDENT OF R&D

    • Officer
    		 285,128 2023-05-08 3

    MCHALE DUNCAN CHIEF MEDICAL OFFICER

    • Officer
    		 97,516 2023-05-08 3

    THORELL MARELLA CHIEF FINANCIAL OFFICER

    • Officer
    		 91,469 2023-05-08 5

    ROSIELLO ROBERT L.

    • Director
    		 0 2023-04-14 2

    PLINIO MARK D. CHIEF COMMERCIAL OFFICER

    • Officer
    		 3,750 2023-01-31 2

    CARRIERE STEPHEN J PRINCIPAL ACCOUNTING OFFICER

    • Officer
    		 1,620 2023-01-19 1

    CHAR DANIEL GENERAL COUNSEL

    • Officer
    		 40,000 2022-07-19 1

    ZUNG JONATHAN B. CHIEF DEVELOPMENT OFFICER

    • Officer
    		 115,000 2022-07-19 1

    EPSTEIN DAVID R

    • Director
    		 93,932 2022-06-30 2

    MELAS KYRIAZI THEO

    • Director
    		 20,000 2022-06-09 1

    MCHUGH JULIE

    • Director
    		 20,000 2022-06-09 1

    HOHNEKER JOHN

    • Director
    		 20,000 2022-06-09 1

    DARZI LORD ARA

    • Director
    		 50,000 2022-06-09 1

    ANDRES JUAN

    • Director
    		 20,000 2022-06-09 1

    MCINNES IAIN B.

    • Director
    		 20,000 2022-06-09 1

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    FLAGSHIP PIONEERING INC.

    AFEYAN NOUBAR

    • 10% Owner
    		 50,427,328 2022-05-27 0

    FLAGSHIP PIONEERING FUND VII GENERAL PARTNER LLC

    FLAGSHIP PIONEERING FUND VII, L.P.

    • 10% Owner
    		 13,698,630 2022-05-27 0

    GUTIERREZ-RAMOS JOSE-CARLOS

    • Director
    		 10,000 2022-04-01 0

    WILLIAMS TONYA

    • Director
    		 0 2022-04-01 0

    SCAVO LUCA CFO

    • Officer
    		 60,000 2022-01-19 0

    PERRY DAVID P

    • Director
    		 17,500 2021-06-08 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 23,030,069 2021-02-02 0

    LIU XIAOLI JACQUELINE PRINCIPAL ACCOUNTING OFFICER

    • Officer
    		 0 2021-01-27 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    AFEYAN NOUBAR

    • 10% Owner
    		 22,900,069 2020-06-29 0

    NUTRITIONAL HEALTH LTP FUND GENERAL PARTNER LLC

    NUTRITIONAL HEALTH LTP FUND, L.P.

    FLAGSHIP PIONEERING INC.

    FLAGSHIP VENTURELABS V MANAGER LLC

    • 10% Owner
    		 3,978,970 2020-06-29 0

    SIMONIAN NANCY A

    • Director
    		 0 2020-06-17 0

    GRAHAM NEIL CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2020-04-08 0

    POOLE JONATHAN CFO

    • Officer
    		 0 2020-01-28 0

    AFEYAN NOUBAR

    • Director
    • 10% Owner
    		 0 2019-06-12 0

    FLAGSHIP VENTURES FUND V GENERAL PARTNER LLC

    FLAGSHIP VENTURELABS V LLC

    FLAGSHIP VENTURES FUND V, L.P.

    FLAGSHIP V VENTURELABS RX FUND, L.P.

    NUTRITIONAL HEALTH DISRUPTIVE INNOVATION FUND, L.P.

    NUTRITIONAL HEALTH SIDE FUND, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I, L.P.

    FLAGSHIP VENTURES OPPORTUNITIES FUND I GENERAL PARTNER LLC

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • Director
    • 10% Owner
    		 18,233,403 2018-05-11 0

    FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC

    FLAGSHIP VENTURELABS IV, LLC

    FLAGSHIP VENTURES FUND IV, L.P.

    FLAGSHIP VENTURES FUND IV-RX, L.P.

    • 10% Owner
    		 18,233,403 2018-05-11 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    		 No longer subject to file 2018-05-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    GILL SIMBA - Director - Officer PRESIDENT & CEO

    		2023-05-10 21:31:15 -0400 2023-05-08 S 3,537 $0.13 d 58,512 direct yes

    THORELL MARELLA - Officer CHIEF FINANCIAL OFFICER

    		2023-05-10 21:31:35 -0400 2023-05-08 S 38,531 $0.13 d 91,469 direct yes

    BODMER MARK - Officer CSO, PRESIDENT OF R&D

    		2023-05-10 21:31:52 -0400 2023-05-08 S 68,014 $0.13 d 285,128 direct yes

    MCHALE DUNCAN - Officer CHIEF MEDICAL OFFICER

    		2023-05-10 21:32:10 -0400 2023-05-08 S 66,730 $0.13 d 97,516 direct yes

    THORELL MARELLA - Officer CHIEF FINANCIAL OFFICER

    		2023-05-09 16:09:37 -0400 2023-05-07 M 130,000 a 130,000 direct

    THORELL MARELLA - Officer CHIEF FINANCIAL OFFICER

    		2023-05-09 16:09:37 -0400 2023-05-07 M 130,000 d 390,000 direct

    GILL SIMBA - Director - Officer PRESIDENT & CEO

    		2023-05-09 16:09:17 -0400 2023-05-07 M 23,437 a 62,049 direct

    GILL SIMBA - Director - Officer PRESIDENT & CEO

    		2023-05-09 16:09:17 -0400 2023-05-07 M 23,437 a 351,563 direct

    BODMER MARK - Officer CSO, PRESIDENT OF R&D

    		2023-05-09 16:08:53 -0400 2023-05-07 M 132,500 a 353,142 direct

    BODMER MARK - Officer CSO, PRESIDENT OF R&D

    		2023-05-09 16:08:53 -0400 2023-05-07 M 132,500 d 397,500 direct

    MCHALE DUNCAN - Officer CHIEF MEDICAL OFFICER

    		2023-05-09 16:08:35 -0400 2023-05-07 M 130,000 a 164,246 direct

    MCHALE DUNCAN - Officer CHIEF MEDICAL OFFICER

    		2023-05-09 16:08:35 -0400 2023-05-07 M 130,000 d 390,000 direct

    GILL SIMBA - Director - Officer PRESIDENT & CEO

    		2023-05-10 17:11:53 -0400 2023-05-07 M 23,437 d 351,563 direct

    ROSIELLO ROBERT L. - Director

    		2023-04-18 17:12:44 -0400 2023-04-14 A 40,000 a 40,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    EVELO BIOSCIENCES INC EVLO 2023-05-31 22:15:04 UTC 0.4825 4.5775 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 21:45:04 UTC 0.4825 4.5775 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 21:15:03 UTC 0.4825 4.5775 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 20:45:04 UTC 0.4825 4.5775 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 20:15:06 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 19:45:04 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 19:15:21 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 18:45:03 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 18:15:04 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 17:45:03 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 17:15:05 UTC 0.452 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 16:45:04 UTC 0.462 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 16:15:04 UTC 0.462 4.608 350000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 15:45:03 UTC 0.462 4.608 300000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 15:15:04 UTC 0.462 4.608 300000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 14:45:04 UTC 0.462 4.608 250000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 14:15:03 UTC 0.462 4.608 250000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 13:45:04 UTC -6.7267 11.7967 250000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 13:15:04 UTC -6.7267 11.7967 250000
    EVELO BIOSCIENCES INC EVLO 2023-05-31 12:45:04 UTC -6.7267 11.7967 250000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments